Literature DB >> 10903723

Nitric oxide induces thymocyte apoptosis via a caspase-1-dependent mechanism.

X Zhou1, S A Gordon, Y M Kim, R A Hoffman, Y Chen, X R Zhang, R L Simmons, H R Ford.   

Abstract

We previously showed that NO induces apoptosis in thymocytes via a p53-dependent pathway. In the present study, we investigated the role of caspases in this process. The pan-caspase inhibitor, ZVAD-fmk, and the caspase-1 inhibitor, Ac-YVAD-cho, both inhibited NO-induced thymocyte apoptosis in a dose-dependent manner, whereas the caspase-3 inhibitor, Ac-DEVD-cho, had little effect even at concentrations up to 500 microM. ZVAD-fmk and Ac-YVAD-cho were able to inhibit apoptosis when added up to 12 h, but not 16 h, after treatment with the NO donor S-nitroso-N-acetyl penicillamine (SNAP). Caspase-1 activity was up-regulated at 4 h and 8 h and returned to baseline by 24 h; caspase-3 activity was not detected. Cytosolic fractions from SNAP-treated thymocytes cleaved the inhibitor of caspase-activated deoxyribonuclease. Such cleavage was completely blocked by Ac-YVAD-cho, but not by Ac-DEVD-cho or DEVD-fmk. Poly(ADP-ribose) polymerase (PARP) was also cleaved in thymocytes 8 h and 12 h after SNAP treatment; addition of Ac-YVAD-cho to the cultures blocked PARP cleavage. Furthermore, SNAP induced apoptosis in 44% of thymocytes from wild-type mice; thymocytes from caspase-1 knockout mice were more resistant to NO-induced apoptosis. These data suggest that NO induces apoptosis in thymocytes via a caspase-1-dependent but not caspase-3-dependent pathway. Caspase-1 alone can cleave inhibitor of caspase-activated deoxyribonuclease and lead to DNA fragmentation, thus providing a novel pathway for NO-induced thymocyte apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903723     DOI: 10.4049/jimmunol.165.3.1252

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Increased apoptosis of CD20+ IgA + B cells is the basis for IgA deficiency: the molecular mechanism for correction in vitro by IL-10 and CD40L.

Authors:  Zaheed Husain; Nichol Holodick; Caitlin Day; Irma Szymanski; Chester A Alper
Journal:  J Clin Immunol       Date:  2006-04-26       Impact factor: 8.317

2.  Role of thromboxane A2 in the induction of apoptosis of immature thymocytes by lipopolysaccharide.

Authors:  Paulo N Rocha; Troy J Plumb; Lisa A Robinson; Robert Spurney; David Pisetsky; Beverly H Koller; Thomas M Coffman
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

Review 3.  Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation.

Authors:  Naveen Challagundla; Bhaskar Saha; Reena Agrawal-Rajput
Journal:  Immunol Res       Date:  2022-05-24       Impact factor: 4.505

Review 4.  Pyroptosis: host cell death and inflammation.

Authors:  Tessa Bergsbaken; Susan L Fink; Brad T Cookson
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

Review 5.  Nitrosothiols in the immune system: signaling and protection.

Authors:  Pablo Hernansanz-Agustín; Alicia Izquierdo-Álvarez; Almudena García-Ortiz; Sales Ibiza; Juan M Serrador; Antonio Martínez-Ruiz
Journal:  Antioxid Redox Signal       Date:  2012-08-17       Impact factor: 8.401

6.  Gene expression alterations in immune system pathways in the thymus after exposure to immunosuppressive chemicals.

Authors:  Rachel Frawley; Kimber White; Ronnetta Brown; Deborah Musgrove; Nigel Walker; Dori Germolec
Journal:  Environ Health Perspect       Date:  2010-11-01       Impact factor: 9.031

Review 7.  Focus on the Mechanisms and Functions of Pyroptosis, Inflammasomes, and Inflammatory Caspases in Infectious Diseases.

Authors:  Haichao Song; Bintong Yang; Ying Li; Aidong Qian; Yuanhuan Kang; Xiaofeng Shan
Journal:  Oxid Med Cell Longev       Date:  2022-01-29       Impact factor: 6.543

Review 8.  Mutagenic Consequences of Sublethal Cell Death Signaling.

Authors:  Christine J Hawkins; Mark A Miles
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.